…s available at https://www.cms.gov/​CCIIO/​Resources/​Regulations-and-Guidance/​index.html . [ 31 ] While we recognized that the number of HHS-HCC changes we proposed was significantly higher than in previous annual notices of benefit and payment parameters, we noted in the propo…

…s available at https://www.cms.gov/​CCIIO/​Resources/​Regulations-and-Guidance/​index.html . [ 31 ] While we recognized that the number of HHS-HCC changes we proposed was significantly higher than in previous annual notices of benefit and payment parameters, we noted in the propo…

…decennial censuses, including some material modifications that have a number of downstream effects, such as IPPS hospital reclassification changes. These bulletins established revised delineations for Metropolitan Statistical Areas, Micropolitan Statistical Areas, and Combined St…

…laims for revised/additional imaging orders and how CMS might mitigate negative downstream effects on ordering professionals whose CDSM data were erroneously reported on claims to accommodate this scenario. Another commenter also requested clarification around the applicability a…

…n Categories (HCC) version 28 for beneficiary risk adjustment; (10) eliminating downside financial risk for low volume hospitals; (11) aligning the date range used for episode attribution; (12) removing health equity plans and health related social needs data reporting; (13) broa…

… parties in conversation on potential implications to budget neutrality and the downstream impacts on the PFS conversion factor. A few commenters stated that they did not agree with the proposal until the current APCM codes have been widely implemented and researched. Other comme…

… antireflux microcatheter, demonstrated statistically significant reductions in downstream distribution of embolic particles with the antireflux catheter and increases in tumor deposition (p < 0.05). [ 13 ] The second singlecenter retrospective study was conducted with 22 patient…

…lmArray ® Pneumonia Panel c. ContaCT d. Supersaturated Oxygen (SSO 2 ) Therapy (DownStream® System) e. Eluvia TM Drug-Eluting Vascular Stent System (Eluvia) f. GammaTile g. Hemospray® Endoscopic Hemostat h. IMFINZI® (durvalumab) and TECENTRIQ® (atezolizumab) i. Soliris k. The Spi…

…lmArray ® Pneumonia Panel c. ContaCT d. Supersaturated Oxygen (SSO 2 ) Therapy (DownStream® System) e. Eluvia TM Drug-Eluting Vascular Stent System (Eluvia) f. GammaTile g. Hemospray® Endoscopic Hemostat h. IMFINZI® (durvalumab) and TECENTRIQ® (atezolizumab) i. Soliris k. The Spi…

…eligible clinician on an ASM participant's clinician list would be considered a downstream participant in ASM, and the ASM participant would be required to contractually bind all downstream participants to comply with all laws pertaining to any patient-identifiable data requested…

…eligible clinician on an ASM participant's clinician list would be considered a downstream participant in ASM, and the ASM participant would be required to contractually bind all downstream participants to comply with all laws pertaining to any patient-identifiable data requested…

…www.cms.hhs.gov/​Medicare/​Medicare-Fee-for-Service-Payment/​AcuteInpatientPPS/​index.html . Click on the link on the left side of the screen titled, “FY 2017 IPPS Final Rule Home Page” or “Acute Inpatient—Files for Download”. The LTCH PPS tables for this FY 2017 final rule are a…

…w participation agreement under the Shared Savings Program or take on increased downside risk, and their overall investment in the program. One commenter supported raising the quality performance standard and allowing ACOs that meet that standard to receive full shared savings, p…

… to expand it to similarly require the issuer to ensure its relevant employees, downstream entities and delegated entities also cooperate with any audit or compliance review under this section. In new proposed paragraph (d)(2)(ii), we proposed to require issuers to submit complet…

…his final rule to indicate that plans and providers are not responsible for the downstream privacy and security of PHI. Response: Regarding commenters' interest in a “safe harbor” provision for covered entities when data is transmitted to a third-party app, we do not have the aut…